Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control study

The 21-gene recurrence score (RS) is increasingly being used for patients with early stage, hormone receptor-positive, Her-2-negative breast cancer. However, these results are largely from populations with infiltrating ductal carcinoma (IDC). The clinical value of RS testing in mucinous carcinoma ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Chen, Xiaosong, Lin, Lin, Fei, Xiaochun, Garfield, David H., Hong, Jin, Gao, Weiqi, Zhu, Siji, Wu, Jiayi, Huang, Ou, He, Jianrong, Li, Yafen, Zhu, Li, Chen, Weiguo, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160674/
https://www.ncbi.nlm.nih.gov/pubmed/30271480
http://dx.doi.org/10.7150/jca.27291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160674/
https://www.ncbi.nlm.nih.gov/pubmed/30271480
http://dx.doi.org/10.7150/jca.27291

Ejemplares similares